Recode Studios IPO: 234x Subscription, GMP ₹50

Recode Studios IPO has stayed in focus across Reddit and social media as the SME issue closed after a heavily oversubscribed three-day window. The issue opened on May 5, 2026 and closed on May 7, 2026, with listing scheduled on the BSE SME platform on May 12, 2026. Conversations have centred on two moving parts - the sharp subscription numbers and the grey market premium (GMP) that multiple trackers have quoted differently at different times. The IPO is a bookbuilding issue with a price band of ₹150 to ₹158 per share and a face value of ₹10. The total issue size is stated as ₹44.59 crore, split between a fresh issue and an offer for sale. Several posts also highlighted the post-issue market capitalisation at the upper price band, pegged at ₹168.18 crore. Below is a fact-based breakdown of what is known from the widely shared public details.

Key dates: subscription, allotment, and listing

Recode Studios IPO opened for subscription on May 5, 2026 and closed on May 7, 2026. The allotment is widely cited as being finalised around May 8, 2026. The equity shares are proposed to be listed on the BSE SME exchange. The tentative listing date repeated across posts is May 12, 2026. Because it is an SME listing, investors have also discussed the practical point that liquidity and price movement can differ from mainboard stocks. Many social posts have framed the trade as a “listing day” event, but the official schedule still matters more than speculation. The registrar mentioned in the shared details is Mudra RTA Ventures Pvt Ltd. Applications were discussed as being routed through UPI or ASBA, with ASBA available via net banking.

Price band, face value, and lot size maths

The IPO price band is ₹150 to ₹158 per share, with a face value of ₹10 per share. The lot size is 800 shares. For retail applicants, several posts stated the minimum is 2 lots, or 1,600 shares. At the upper price of ₹158, that minimum application amount works out to ₹252,800. Some sources also repeated an 800-share minimum application detail alongside a ₹126,400 figure, which corresponds to one lot at the upper price. However, the repeated retail rule of 2 lots means most retail applicants discussed a higher cheque size. Social chatter also listed NII slabs such as sNII at 3 lots (2,400 shares) and bNII starting at 8 lots (6,400 shares), with the corresponding rupee outlay quoted at the upper band. These cheque sizes have been a core talking point because they raise the entry barrier for many small investors in SME IPOs.

Issue structure and size as shared publicly

The total issue size is reported as 28,22,400 shares aggregating to ₹44.59 crore. The split shared in multiple posts is a fresh issue of 25,03,200 shares aggregating to ₹39.55 crore and an offer for sale of 3,19,200 shares aggregating to ₹5.04 crore. One widely shared detail states pre-issue shareholding stands at 81,41,144 shares and will increase to 1,06,44,344 shares post-issue. At the upper end of the band (₹158), the post-issue market capitalisation is cited as ₹168.18 crore. These numbers have been referenced often because they allow investors to compare the company’s size with other SME listings. The issue is consistently described as a bookbuilding issue. Posts also describe Recode Studios as operating in beauty and personal care products, which shaped the debate on whether the category is “hot” or merely riding IPO momentum.

Subscription: from Day 1 build-up to the final spike

The most repeated final subscription figure is 234.64x overall at close. Category-wise, multiple posts cited QIB at 137.99x, NII at 404.76x, and retail at 216.65x. Social feeds also circulated a day-wise table that showed a sharp jump on Day 3 compared with the first two days. Another set of posts discussed an earlier milestone of about 33.40x overall by Day 2, with QIB around 3.54x, NII 56.41x, and retail 40.56x at that point. This contrast is important because it shows how quickly SME IPO demand can accelerate near the close. The strong NII number became the headline in many threads because it was the highest among the categories. Investors also debated what oversubscription means in practice, with many noting it signals demand but does not set the listing price.

GMP discussion: why the number varies across trackers

GMP has been the second big driver of online interest, but the posts do not point to a single, consistent value. One widely shared “live” snapshot quoted current GMP at ₹50, with the previous GMP also at ₹50, last updated about 19 hours earlier. Another shared line referenced GMP at ₹48 on one day, implying about 30.38% over the ₹158 cap price. Several posts repeatedly mentioned ₹42 as a GMP level, including an allotment-day row showing an estimated listing price of ₹200 (26.58%) when GMP was ₹42. There was also a circulating snippet that described the grey market premium as ₹11, calling it “mild interest” and estimating a listing near ₹169, which differs from the ₹200-₹208 estimates attached to ₹42-₹50 GMP. Put together, the social conversation reflects that GMP changes quickly and different sources may publish different snapshots. Importantly, several posts explicitly cautioned that GMP is unofficial and does not guarantee listing gains.

What the GMP implies for estimated listing price, on paper

Where GMP is quoted as ₹50 on an issue price of ₹158, some posts estimate a listing price near ₹208. With GMP at ₹48, the same method produces an estimated listing price near ₹206. With GMP at ₹42, the estimate circulated was about ₹200. These are not official forecasts, but they show how social media frames expectations in simple arithmetic. Some posts also expressed the GMP as a percentage, such as about 31.6% at ₹50 over the cap price and about 26.58% at ₹42. At the same time, the presence of a ₹11 GMP snippet illustrates the risk of relying on a single headline number. Many investors in discussions highlighted that GMP can be volatile and can change materially ahead of listing. The only certainty from the shared information is the schedule - listing is expected on May 12, 2026 on BSE SME.

Valuation and ratios being debated in threads

Apart from subscription and GMP, some posts surfaced a valuation snapshot and operating ratios. The post-issue market capitalisation at the upper band is cited as ₹168.18 crore. A valuation section also circulated ROE at 46.37%, ROCE at 34.47%, debt-to-equity at 0.86, RoNW at 37.64%, PAT margin at 6.91%, and EBITDA margin at 12.82%. These figures were often quoted as a quick check for profitability and leverage, without deeper context in the threads themselves. Because the discussion is social-media driven, investors tended to compare these numbers with other SME IPO summaries rather than full financial statements. Some posts also claimed the company planned to use IPO proceeds for expansion, including a new warehouse in Ludhiana and spending on marketing and promotion. Another set of circulated lines mentioned “marketing and promotion” as a use of funds, but without a consistent detailed breakdown across posts. As always, investors noted that fundamentals should be weighed more than grey market signals.

What investors are watching into the May 12 listing

The near-term focus in online discussion is on whether oversubscription and GMP will translate into a strong debut on BSE SME. Retail participation is being discussed as unusually high, with retail subscription cited at 216.65x in the final tally. Many posts also noted that NII demand was the most aggressive, at 404.76x, which can sometimes amplify listing-day volatility. Another theme was the high minimum retail cheque size due to the 2-lot rule, which changes the risk profile for small investors compared with mainboard IPOs. Several users also shared checklists such as verifying allotment status and watching updated GMP prints, while acknowledging GMP is unofficial. The timeline is clear in the shared information: allotment around May 8, and listing on May 12. From here, the discussion tends to shift from subscription data to actual traded prices and volumes after listing. Until then, the most responsible takeaway from the social chatter is that demand indicators are strong, but outcomes remain uncertain.